MOD-5014

DB17715InvestigationalProtein Based Therapies

MOD-5014 is a long-acting carboxy-terminal peptide (CTP)-modified Factor IIa. It is being investigated for the treatment of hemophilia.

Mechanism: Pharmacologically active on Coagulation factor VII
Curator reviewed
Code names: MOD-5014

Resolves to

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with MOD-5014, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.